Enteropathy induced by clofazimine (Lamprene) in AIDS
Mondain-Miton, V.; Chichmanian, R.M.; Dellamonica, P.
Therapie 49(5): 462-463
1994
ISSN/ISBN: 0040-5957 PMID: 7855769 Document Number: 431440
Document emailed within 1 workday
Related Documents
Mathur, A.; Venkatesan, K.; Bharadwaj, V.P.; Ramu, G. 1985: Evaluation of effectiveness of clofazimine therapy. I. Monitoring of absorption of clofazimine from gastrointestinal tract Indian Journal of Leprosy 57(1): 146-148Oimomi, M.; Kida, S.; Uenoyama, R.; Kusaka, T.; Baba, S. 1976: Gluten-induced enteropathy Nihon Rinsho. Japanese Journal of Clinical Medicine 34(2): 395-397
Spichtin, H.; Fahrländer, H. 1973: Catamnestic studies on patients with gluten-induced enteropathy Schweizerische Medizinische Wochenschrift 103(16): 593-599
Tărmure, S.; Grigorescu, M.; Cristea, A.; Togănel, E.; Dumitra, D. 2002: Antiendomysial and antitissue transglutaminase antibodies in gluten-induced enteropathy Romanian Journal of Gastroenterology 11(2): 91-95
Bloch, K.J.; Hassell, L.A.; Bloch, M.B.; Bishara, S.M. 1987: Acute and chronic enteropathy induced in the rat by injection of immune complexes Advances in Experimental Medicine and Biology 216b: 1599-1607
Yoon, K.H.; Ng, S.C. 1998: A case of sulindac-induced enteropathy resulting in jejunal perforation Annals of the Academy of Medicine Singapore 27(1): 116-119
Sobocinski, P.Z.; Knutsen, G.L.; Canterbury, W.J.; Hauer, E.C. 1979: Altered zinc homeostasis and hepatic accumulation of metallothionein in indomethacin-induced enteropathy Toxicology and Applied Pharmacology 50(3): 557-564
Güller, R.; Anabitarte, M.; Mayer, M. 1986: Collagenous sprue and ulcerative jejuno-ileitis in a patient with gluten-induced enteropathy Schweizerische Medizinische Wochenschrift 116(39): 1343-1349
Matsumoto, T.; Nakamura, S.; Koga, H.; Matsui, T.; Iida, M.; Yao, T. 2008: Nonsteroidal anti-inflammatory drug-induced enteropathy and chronic nonspecific multiple ulcers of the small intestine Nihon Rinsho. Japanese Journal of Clinical Medicine 66(7): 1323-1329
Kumar, B. 1991: Clofazimine--a review Indian Journal of Leprosy 63(1): 78-92
Gurfinkel, P.; Pina, J.C.; Ramos-e-Silva, M. 2009: Use of clofazimine in dermatology Journal of Drugs in Dermatology: Jdd 8(9): 846-851
Silva, D. 1978: Treatment of Lobo's disease with clofazimine (B 663) Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 71(6): 409-412
Fdez-Freire, L.R.íg.; Serrano Gotarredona, A.; Bernabeu Wittel, J.; Pulpillo Ruiz, A.; Cabrera, R.ío.; Navarrete Ortega, M.; Conejo-Mir, J.án. 2005: Clofazimine as elective treatment for granulomatous cheilitis Journal of Drugs in Dermatology: Jdd 4(3): 374-377
Mathies, H.; Ress, U. 1970: Experimental studies in man on hyaluronidase inhibiting effect of clofazimine Arzneimittel-Forschung 20(12): 1838-1840
Sritharan, M. 1993: Studies on the tissue distribution of liposome-associated clofazimine, an antileprosy drug Methods and Findings in Experimental and Clinical Pharmacology 15(2): 107-111
Sarracent Pérez, J.; Finlay, C.M. 1982: Inhibition of the selective release of lysosomal enzymes produced by clofazimine in macrophages in culture Revista Cubana de Medicina Tropical 34(1): 3-10
Kumar, B.; Bahadur, B.; Broor, S.L.; Kaur, S.; Gangwar, D.N.; Malik, A.K. 1982: Study of toxicity of clofazimine with special reference to structural and functional status of small intestine Leprosy in India 54(2): 246-255
Chandorkar, A.G.; Burte, N.P.; Gade, R.K.; Bulakh, P.M. 1984: Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy Indian Journal of Leprosy 56(1): 63-70
Grob, J.J.; Mège, J.L.; Collet-Villette, A.M.; Bonerandi, J.J. 1989: Dermatitis ulcerosa or superficial granulomatous pyoderma. Functional abnormalities of the neutrophils and transient efficacy of clofazimine Annales de Dermatologie et de Venereologie 116(11): 829-831
Sarracent, J.; Finlay, C.M. 1982: Phagocytosis and intracellular degradation of 125I-labelled immune complexes by Clofazimine treated macrophage cultures Clinical and Experimental Immunology 48(1): 268-272